MESSAGE FROM CEO - FALYN KATZ | |
|
Events with Purpose
As the leaves change colour and the air gets cooler, Melanoma Canada is set to bring you some amazing events with purpose this fall and winter! Speaking of amazing, our Golf & Grill tournament has grown. It’s not just in one city anymore – over the past few weeks, we’ve taken it to Vancouver and Montreal, as well as brought the Canadian Event Industry Award-nominated event back to the Greater Toronto Area (GTA). Golf & Grill is certainly not your regular golf tournament!
| |
Brian "Red" Hamilton with Melanoma Canada, CEO, Falyn Katz | | |
|
One Skin Check at a Time - Mole Mobile Making Progress in Skin Cancer Detection | Imagine travelling through 29 cities, covering a distance of 5,816 kilometers, and performing over 3,281 skin checks. That’s exactly what the Mole Mobile initiative has achieved since its launch in May 2023. | |
Help Smash Out Skin Cancer in Toronto on September 30, 2023 | |
|
With over 89,000 Canadians facing skin cancer diagnoses and incidence rates on the rise, it's time to Smash Out Skin Cancer together.
Get your paddle ready and join us at Maple Downs on September 30th to help save lives! Players of all ages and skill levels will compete in an exhilarating best-of-three match tournament. The event boasts:
-
Celebrity Guests - A special bonus round where the top 3 fundraising teams take on celebrity guests BILLY BALDWIN & DANIEL NESTOR. Check out a personal video message from the celebrities!
-
Participant Swag Bag - An impressive Smash Out Skin Cancer Swag Bag loaded with gifts from proud sponsors!
-
The Pickleball - A Pickle "Ball" celebration after the tournament, treating guests to a gala-style dinner, an awards ceremony, live music, and the chance to mingle with celebrity guests and fellow pickleball enthusiasts. PLUS, don’t miss the Silent Auction showcasing incredible prizes, including a lesson from Canadian professional tennis player, Daniel Nestor. Get Tickets
Experience the thrill in an outdoor venue where sun safety takes the center court! The tournament will kick off between 9 AM - 10 AM (ET), with each team receiving a scheduled tournament time in advance.
Don't miss your chance – secure your spot and together let's Smash Out Skin Cancer!
| |
Donate to the Mole Mobile - Skin Cancer Screening Unit | |
Todd Keirsted
Like 1 in 3, I am battling skin cancer.
It has been a rollercoaster of emotions as I am letting the world know for the first time that I have been diagnosed with cancer. I am throwing my pride away and deciding to share my story and journey in the hope that I can bring awareness to how important sunscreen and covering up in the sun really is.
| |
|
|
Meet Sarah Shulman
The Pickleball Enthusiast Defying Skin Cancer
My name is Sarah Shulman, and my story begins in the Dog Days of the summer of 1997. Little did I know that a small skin irritation that surfaced just above my right eye that week would be the first sign of a life-long journey with skin cancer.
| |
|
Uveal Melanoma – Wins and Losses | |
Kimmtrak and Keytruda
The INESSS recommendation for Kimmtrack is that it was refused registration, which means it won't be approved.
| |
|
Canadian Clinical Trial Aims to Boost Immunotherapy Response in Advanced Melanoma Patients | Researchers in Montreal and Toronto have shown that the trillions of bacteria living within the human gastrointestinal system, known as the gut microbiome, could be essential for a melanoma patient to respond to immunotherapy. | |
|
Unresectable & Metastatic Treatment Update | Melanoma Canada submitted a survey for Nivolumab and Relatlimab on July 10th, 2023. The review process started on July 25th, and feedback will be accepted until January 18, 2024. | |
|
|
V940 and Keytruda
Merck and Moderna initiate phase 3 study evaluating V940 (mRNA-4157) in combination with Keytruda (Pembrolizumab) for adjuvant treatment of patients with resected high-risk (stage IIB-IV) melanoma. Read full press release here.
| |
Opdivo
BMS has received a positive recommendation from the CHMP (Committee for Medicinal Products for Human Use) of the European Medicines Agency for the approval of Opdivo (Nivolumab). Opdivo is recommended as a monotherapy for the adjuvant treatment in adults and adolescents aged 12 and older with completely resected stage IIB or IIC melanoma. This recommendation is based on the positive results from the Phase 3 CheckMate-76K trial, where Opdivo showed a significant and clinically meaningful improvement in recurrence-free survival compared to a placebo. Read full press release here.
| |
|
GlobalSkin is looking for 10,000 people like you and your community members to take part in the Global research on the impact of dermatological disease (GRIDD) study by completing a 10–20-minute online survey.
The online survey is open until September 28, 2023.
| |
Tanny Nadon Caregiver Award and Spotlight | |
Do you know a remarkable caregiver who deserves recognition for their support to someone affected by a skin, hair, or nail condition? Here's your chance to honour someone special in your community!
The deadline to nominate a caregiver for the CSPA-sponsored Tanny Nadon Caregiver Award & Spotlight is October 15, 2023.
Nominate someone special using the nomination form available here.
| |
|
A big congratulations to the Grand Prize winner of our BurnWatch Raffle! Joy Mulder held lucky ticket, D-3963 and won big in our raffle drawn on September 4th.
The winner's awesome prize included:
- A cool 2023 Nissan Kicks SR car
- A sun-safe Club Med Vacation for Two
- A $5,000 shopping Columbia Sportswear shopping spree
- Plus, a whole year's supply of Neutrogena Sunscreen for fun under the sun!
You're all winners for supporting our cause. Your help funds our Mole Mobile, which gives free skin cancer screenings across Canada for 5 years.
Learn More about Burnwatch
| |
|
We are thrilled to announce the 50/50 Raffle winner was ticket number, B-1141 This lucky winner will take home 50% of the total jackpot of $4,010
The remaining 50% of the funds raised will go towards supporting Melanoma Canada's Mole Mobile as it travels across Canada to give free skin cancer screenings to those who need them most.
Learn More About Our Mole Mobile
| | | | |
